Ed Perlmutter

Rescheduling cannabis from a schedule one drug to a schedule three drug was top of mind for former U.S. Rep. Ed Perlmutter, who spoke exclusively to Benzinga at its Cannabis Capital Conference in late September. The former U.S. representative, who has been an influential figure in the cannabis...

At the Benzinga Cannabis Capital Conference in Chicago, key figures in the cannabis industry engaged in discussions about the U.S. Senate Banking Committee passing the Secure and Fair Enforcement Regulation (SAFER) Banking Act — and a surprising twist involving cryptocurrency, offering...

By Sahar Ayinehsazian, Hon. Ed Perlmutter and J. Devoy Dubuque Prior to its sudden shutdown, Silicon Valley Bank had a reputation for serving start-ups and entrepreneurs. Amongst its lesser-known clientele were cannabis-related businesses, which have long struggled with access to depository and...

Despite the fact that 23 U.S. states and the District of Colombia have legalized medical marijuana sales, the drug is still seen as a Schedule I illegal substance in the eyes of the federal government. The Obama administration has promised to allow states to make their own laws regarding the...